Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center

News from IVAC - January 2023

January 2023

IVAC engages with Jordan on introduction of the Pneumococcal Conjugate Vaccine (PCV) – a life-saving vaccine for children

Pneumonia continues to be the number one infectious killer of young children globally. In the World Health Organization (WHO)’s Eastern Mediterranean (EMRO) region, each year an estimated 923,000 children under 5 years of age (U5) die, with pneumonia accounting for over 20% of deaths among this age group (UNICEF, 2022). PCV protects against infections caused […]

Read More >
January 2023

IVAC Collaborates with Global Partners to Tackle Cervical Cancer

Worldwide, cervical cancer is the fourth most common cancer among women, with an estimated 604,000 new cases and 342,000 cervical cancer-related deaths reported in 2020. Two types of HPV contribute to nearly 50% of high-grade cervical cancers, underscoring the need for continued prevention, screening, and education. Vaccination against HPV remains the primary prevention method globally; […]

Read More >
January 2023

IVAC’s Vaccine Hesitancy Training Course Has a Successful Test Run in Uttar Pradesh, India 

It is well-known that vaccines save lives, but their effectiveness continues to be undermined by rampant vaccine misinformation. Healthcare workers have voiced that they are not equipped with the right information or preparation to combat this often polarizing and sensitive topic. To address this need, IVAC researchers recently developed a training course aimed toward healthcare […]

Read More >
International Vaccine Access Center

Subscribe to our Newsletter

Subscribe now
No thanks